Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report published on Tuesday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of AMPE stock opened at $0.00 on Tuesday. The company has a market capitalization of $2,394.00, a P/E ratio of 0.00 and a beta of 3.66. The company’s 50 day moving average price is $0.01 and its two-hundred day moving average price is $0.01. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $2.47.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.